TaxTMI Login
🎉 Festive Offer: Flat 15% off on all plans! →⚡ Don’t Miss Out: Limited-Time Offer →
TaxTMI 
Login
Just a moment...
Press 'Enter' to add multiple search terms. Rules for Better Search
of 
of 
No Folders have been created
Are you sure you want to delete "My most important" ?
NOTE:
of of 
All Notifications
of of All Notifications
Note
Bookmark
Share
Don't have an account? Register Here
of <h1>Central Government Exempts COVID-19 Medicines from Integrated Tax; Tocilizumab and Amphotericin B at Nil Rate Until December 31, 2021.</h1> The Central Government, under the Integrated Goods and Services Tax Act, 2017, has issued a notification exempting specified COVID-19 medicines from the integrated tax. Effective from October 1, 2021, until December 31, 2021, the exemption applies to medicines such as Tocilizumab and Amphotericin B, which are taxed at a nil rate. Other medicines like Remdesivir, Heparin, and Favipiravir are taxed at a reduced rate of 5%. This decision, based on the Council's recommendations, aims to alleviate public health burdens during the pandemic.
TaxTMI 
